CompuGroup Medical SE KgaA (WBO:COP) LT-Debt-to-Total-Asset : 0.39 (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is CompuGroup Medical SE KgaA LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. CompuGroup Medical SE KgaA's long-term debt to total assests ratio for the quarter that ended in Mar. 2025 was 0.39.

CompuGroup Medical SE KgaA's long-term debt to total assets ratio increased from Mar. 2024 (0.37) to Mar. 2025 (0.39). It may suggest that CompuGroup Medical SE KgaA is progressively becoming more dependent on debt to grow their business.

CompuGroup Medical SE KgaA LT-Debt-to-Total-Asset Historical Data

The historical data trend for CompuGroup Medical SE KgaA's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CompuGroup Medical SE KgaA LT-Debt-to-Total-Asset Chart

CompuGroup Medical SE KgaA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.32

0.35

0.38

0.39

0.42

CompuGroup Medical SE KgaA Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.37	0.39	0.40	0.42	0.39

CompuGroup Medical SE KgaA LT-Debt-to-Total-Asset Calculation

CompuGroup Medical SE KgaA's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )	/	Total Assets (A: Dec. 2024 )
	=	826.439	/	1965.666
	=	0.42

CompuGroup Medical SE KgaA's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2025 is calculated as

LT Debt to Total Assets (Q: Mar. 2025 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2025 )	/	Total Assets (Q: Mar. 2025 )
	=	795.24	/	2018.395
	=	0.39

CompuGroup Medical SE KgaA (WBO:COP) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

CompuGroup Medical SE KgaA LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of CompuGroup Medical SE KgaA's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

CompuGroup Medical SE KgaA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CompuGroup Medical SE & Co KgaA (WBO:COP) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

CMPUY:USA 0MSD:UK COP:Germany

Address

Maria Trost 21, Koblenz, DEU, 56070

Website

https://www.cgm.com

CompuGroup Medical SE & Co KgaA provides electronic health solutions to healthcare providers through the following segments: Ambulatory information systems, Pharmacy information systems, and Hospital information systems. The Ambulatory information systems segment, which generates maximum revenue, focuses on developing and selling practice management software for registered physicians and medical care centers. This segment offers comprehensive end-to-end solutions that cover all essential clinical, administrative, and billing functions. In addition, its portfolio includes data-driven products, software interfaces for information exchange, medical decision support tools, and pharmaceutical and therapy databases, among other solutions. The company mainly operates in the U.S. and Europe.